Transforming healthcare responses to methamphetamine and emerging drugs
The 2022 Annual NCCRED symposium is being held on Monday 7th November in Canberra. The symposium will present new clinical research findings which have the potential to transform healthcare responses to methamphetamine and emerging drugs. The symposium will showcase emerging research, including presentations from recipients of NCCRED’s Round 4 Seed Funding Grants, NCCRED Scholars and the current work of the Centre. Key themes of the 2022 symposia include:
- New directions in pharmacotherapies for methamphetamine use disorder: cannabidiol, lisdexamfetamine, oxytocin, psilocybin-assisted psychotherapy.
- Intervention research for methamphetamine use disorder: contingency management, cognitive remediation, transcranial magnetic stimulation and neuropsychological assessment.
- Emerging drugs and harm reduction: drug-checking fever detection on the dance floor, GHB, prompt response network, risk communication.
NCCRED’s 2022 symposium is a vital opportunity for all people interested in driving new ways to reduce the harms from methamphetamine and other drugs of emerging concern to Australia.
Join the symposium online or in person in Canberra on 7 November!
For more information, contact National Centre for Clinical Research on Emerging Drugs.
12:00am - 12:00am,
Monday 7 November 2022
CPD Points Available?